External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis

Stroke

Volumn 44, Issue 6, 2013, Pages 1595-1600

  Mazya, Michael V ^a   Bovi, Paolo ^b   Castillo, José ^c   Jatuzis, Dalius ^d   Kobayashi, Adam ^e   Wahlgren, Nils ^a   Ahmed, Niaz ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c Instituto de Salud Carlos III   (Spain)

^d VILNIUS UNIVERSITY   (Lithuania)

^e INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Cerebral infarct; Database; Intracerebral hemorrhage; Prognosis; Stroke management; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; EXTERNAL VALIDITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEDAN SCORE;

CEREBRAL INFARCT; DATABASE; INTRACEREBRAL HEMORRHAGE; PROGNOSIS; STROKE MANAGEMENT; THROMBOLYSIS;

AGED; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84880145172     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000794     Document Type: Article

References (18)

1. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al; SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: Safe Implementation of Treatments in Stroke (SITS) symptomatic intracere-bral hemorrhage risk score. Stroke. 2012;43:1524-1531.
2. Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012;71:634-641.
3. Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71:1417-1423.
4. Cucchiara B, Tanne D, Levine SR, Demchuk AM, Kasner S. A risk score to predict intracranial hemorrhage after recombinant tissue plas-minogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008;17:331-333.
5. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251.
6. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282.
7. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millán M, Muir K et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372:1303-1309.
8. Wahlgren N, Ahmed A, Eriksson N, Aichner F, Bluhmki E, Dávalos A et al, for the SITS-MOST Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profle in randomized controlled trials; Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST). Stroke. 2008;39:3316-3322.
9. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.
10. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.
11. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.
12. Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009;338:b606.
13. Strbian D, Sairanen T, Meretoja A, Pitkäniemi J, Putaala J, Salonen O, et al; Helsinki Stroke Thrombolysis Registry Group. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology. 2011;77:341-348.
14. Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case defnitions. Cerebrovasc Dis. 2012;34:106-114.
15. Gumbinger C, Gruschka P, Böttinger M, Heerlein K, Barrows R, Hacke W, et al. Improved prediction of poor outcome after thromboly-sis using conservative defnitions of symptomatic hemorrhage. Stroke. 2012;43:240-242.
16. Sairanen T, Strbian D, Soinne L, Silvennoinen H, Salonen O, Artto V, et al; Helsinki Stroke Thrombolysis Registry (HSTR) Group. Intravenous thrombolysis of basilar artery occlusion: predictors of recanalization and outcome. Stroke. 2011;42:2175-2179.
17. Rabinstein A, Rundek T. Prediction of outcome after ischemic stroke: the value of clinical scores. Neurology. 2013;80:15-16.
18. Cucchiara B, Kasner S, Tanne D, Levine S, Demchuk A, Messe S, et al; SAINT Investigators. Validation assessment of risk scores to predict post-thrombolysis intracerebral haemorrhage. Int J Stroke. 2011;6:109-111.